Table 2.
Results regarding AA disease burden perception.
Statements* | Consensus % |
---|---|
Disease burden | |
All forms of AA cause considerable psychological disorders (such as anxiety and mood disorders) and lower the QoL for patients and their families. | 86.9 |
Moderate-to-severe AA causes significant psychological disorders and results in a dramatic impact on the QoL for patients and their families. | 91.2 |
Moderate-to-severe AA causes stigmatization in society. | 100 |
Additional lesions in visible areas beside the scalp (eyebrows, eyelashes, beard, etc.) impair the patient’s QoL to a greater extent. | 95.6 |
Moderate-to-severe AA causes significant work and productivity impairment in adults. | 82.5 |
AA is an impairing disease. | 95.6 |
Common observations, perspectives, and practices* | % |
---|---|
Disease burden | |
The rate of referring to a healthcare provider is increased in AA patients compared to the general population without AA. | 78.2 |
AA is perceived as an impairing disease in our society. | 86.9 |
AA is perceived as a disabling disease in our society. | 81.8 |
AA-related impairments and disabilities are not adequately publicized/emphasized enough in media in order to raise public awareness of the AD disease burden. | 78.2 |
Clinical practice | |
I take into consideration the patient’s QoL when making treatment decisions. | 85.5 |
QoL indexes are not used as much as they should be to evaluate AA patients in daily practice in my country. | 100 |
Psychiatric consultations for patients with moderate to severe AA are not performed much as they should evaluate AA patients in daily practice in my country | 81.8 |
*More than 70% of the total participants and of the participants in each country. AA, alopecia areata.